Author

H. H.-L. Huang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:statistical model· 1

Frequent Co-Authors

A. M. Thornton· 1 shared A. N. Brooks· 1 shared A. P. Wiita· 1 shared B. C. Hann· 1 shared B. Zhou· 1 shared C. Y. T. Lam· 1 shared D. Serie· 1 shared G. Xu· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. M. Thornton

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintSep 30, 2021

Serum glycoprotein markers in non-alcoholic steatohepatitis and hepatocellular carcinoma

P. Ramachandran, G. Xu, H. H.-L. Huang…·D. Serie

This study identifies serum glycoprotein markers that distinguish non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) from healthy controls.

DOI 10.1101/2021.09.30.462486

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivFeb 3, 2019

Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma

H. H.-L. Huang, I. D. Ferguson, A. M. Thornton…·A. P. Wiita

The paper shows proteasome inhibitors modulate splicing in multiple myeloma, revealing spliceosome inhibition as a therapeutic target.

DOI 10.1038/s41467-020-15521-4

humanproteomics

𝕏 PostBluesky